GlassScriptPhysician profile
Leah Graves
NPI 1013317825
$21,222.21
in general payments reported to CMS, 2019-2025
39 companies · $4,332 in 2025
The $4,332 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,587 · 2022: $4,417 · 2023: $4,478 · 2024: $4,408 · 2025: $4,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,001.99 |
| Education | $216.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,218.10 | 2021-2025 | |
| Janssen Biotech, INC. | $2,276.41 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Pfizer INC. | $2,175.85 | 2021-2025 | |
| Amgen INC. | $1,775.53 | 2021-2025 | Evenity, Enbrel, Otezla |
| Ucb, INC. | $1,652.27 | 2021-2025 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $1,508.51 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,016.81 | 2021-2025 | Orencia, Sotyktu |
| Astrazeneca Pharmaceuticals LP | $915.24 | 2021-2025 | Saphnelo |
| Glaxosmithkline, LLC. | $796.02 | 2021-2025 | Benlysta |
| Mallinckrodt Hospital Products INC. | $789.86 | 2021-2025 | Acthar |
| Alexion Pharmaceuticals, INC. | $600.78 | 2021-2025 | Strensiq, Soliris |
| Ani Pharmaceuticals, INC. | $498.05 | 2022-2025 | Purified Cortrophin Gel, Sovuna |
| Radius Health, INC. | $488.12 | 2021-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.00 | 2021-2025 | Ofev, Cyltezo |
| Sobi, INC | $287.89 | 2021-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.